Intravenous oxycodone versus morphine patient-controlled analgesia after uterine artery embolization: a propensity matched case-control study
British Journal of Radiology · 24.10.2026
DOI: 10.1093/bjr/tqag262 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift British Journal of Radiology, online erschienen am 24.10.2026. Verfasst von Warren Clements und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Alfred Health, Melbourne, Australia. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
The use of intravenous oxycodone is still limited in the Interventional Radiology setting. This study aimed to assess the safety and efficacy of intravenous oxycodone used in patient-controlled analgesia (PCA) after uterine artery embolization (UAE), compared to morphine.
Methods
Retrospective case-control study. The study group consisted of patients treated with UAE between March and December 2024, using an oxycodone protocol. The control group consisted of a previously published dataset using morphine protocol. Primary outcomes were safety and the incidence of severe nausea.
Results
There were 57 patients in the oxycodone group compared to 69 in the morphine group. After propensity score matching, this left 43 in the oxycodone group and 60 in the morphine group. Groups were similar in terms of background demographics, however the use of smaller 355-500 µm polyvinyl alcohol particles were higher in the oxycodone group (100% vs 18%, P < .001). No analgesic-related adverse events were observed in either group. The incidence of severe nausea was lower in the oxycodone group (43.3% vs 37.2%, P = .533) despite a higher rate of post-embolization syndrome (65.1% vs 48.3%, P = .091). After multiparametric logistic regression, oxycodone was associated with a 64% reduced odds of severe nausea (OR 0.36, P = .217).
Conclusions
Intravenous oxycodone PCA is safe and showed a trend toward a lower incidence of severe nausea compared with morphine PCA. Advances in knowledge There is limited evidence of the use of oxycodone PCA to treat post-embolization syndrome. This study showed it was safe and resulted in reduced nausea compared to morphine.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Alfred Health, Melbourne, Australia.
- Department of Surgery, Monash University, Australia.
- National Trauma Research Institute, Central Clinical School, Monash University, Melbourne, Australia.
- Mater Misericordiae University Hospital, Department of Radiology, Dublin, Ireland.
- Department of Medical Imaging, Monash Health, Melbourne, Australia.
ORCID-Profile: Warren Clements, Mark Bolger, Rohan Nandurkar, Salam Findakly
Zitieren
APA
Clements, W., Markakis, D., Koukounaras, J., Venn, G., Bolger, M., Nandurkar, R., Findakly, S., & Lukies, M. W. (2026). Intravenous oxycodone versus morphine patient-controlled analgesia after uterine artery embolization: a propensity matched case-control study. British Journal of Radiology. https://doi.org/10.1093/bjr/tqag262
Vancouver
Clements W, Markakis D, Koukounaras J, Venn G, Bolger M, Nandurkar R, et al. Intravenous oxycodone versus morphine patient-controlled analgesia after uterine artery embolization: a propensity matched case-control study. British Journal of Radiology. 2026. doi:10.1093/bjr/tqag262
BibTeX
@article{Clements2026,
author = {Clements, Warren and Markakis, Demi and Koukounaras, Jim and Venn, Georgina and Bolger, Mark and Nandurkar, Rohan and Findakly, Salam and Lukies, Matthew W},
title = {Intravenous oxycodone versus morphine patient-controlled analgesia after uterine artery embolization: a propensity matched case-control study},
journal = {British Journal of Radiology},
year = {2026},
doi = {10.1093/bjr/tqag262}
}
EUVIMED